Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.2 USD | +0.02% |
|
-1.61% | -12.85% |
Jun. 17 | TD Cowen Initiates Alkermes at Buy With $34 Price Target | MT |
Jun. 11 | Transcript : Alkermes plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.85% | 4.09B | |
+16.45% | 44.87B | |
-10.59% | 37.8B | |
+40.49% | 37.61B | |
+28.72% | 31.32B | |
-8.44% | 27.4B | |
+12.32% | 26.32B | |
+41.38% | 14.07B | |
+31.91% | 12.5B | |
-7.18% | 11.23B |
- Stock Market
- Equities
- ALKS Stock
- News Alkermes plc
- Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study